Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Users Online: 2190

 

Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Advertise Contacts Login 
     
REVIEW ARTICLE
Year : 2013  |  Volume : 54  |  Issue : 1  |  Page : 1-4

Helicobacter pylori eradication therapy: A review of current trends


1 Department of Medicine, Gastroenterology Unit, University of Ilorin Teaching Hospital, Ilorin, Nigeria
2 Irrua Specialist Teaching Hospital, Irrua, Nigeria

Correspondence Address:
A B Olokoba
Department of Medicine, Division of Gastroenterology, University of Ilorin Teaching Hospital, P. M. B 1459, Ilorin, Kwara State
Nigeria
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0300-1652.108884

Rights and Permissions

Helicobacter pylori has been implicated in the formation of chronic gastritis, peptic ulcer disease, mucosa-associated lymphoid tissue lymphoma and gastric cancer. Eradication of H. Pylori has been recommended as treatment and prevention for these complications. This review is based on a search of Medline, the Cochrane Database of Systemic Reviews, and citation lists of relevant publications. Subject heading and key words used include H. Pylori, current treatment and emerging therapy. Only articles in English were included. There has been a substantial decline in the H. pylori eradication rates over the years, despite the use of proton pump inhibitor and bismuth salts for triple and quadruple therapies respectively. The reasons for eradication failure are diverse, among them, antibiotic resistance is an important factor in the treatment failure. Primary resistance to clarithromycin or metronidazole significantly affects the efficacy of eradication therapy. This has led to the introduction of second line, third line "rescue," and sequential therapies for resistant cases. Subsequently, new antibiotic combinations with proton-pump inhibitors and bismuth salts are being studied in the last decade, to find out the antibiotics that are capable of increasing the eradication rates. Some of these antibiotics include Levofloxacin, Doxycycline, Rifaximin, Rifampicin, Furazolidone based therapies. Studies are ongoing to determine the efficacy of Lactoferrin based therapy.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed5749    
    Printed123    
    Emailed0    
    PDF Downloaded581    
    Comments [Add]    
    Cited by others 10    

Recommend this journal